Share

RIVENDEL

Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study

Project Objective

To evaluate the effect of ivabradine treatment on endothelial function of patients with coronary artery disease undergoing PCI

Start/End Date

January 2013 - December 2014; data analysis ongoing

Principal Investigator

  • Dr. Fabio Mangiacapra - Principal Investigator
  • Prof. Germano Di Sciascio

Host Institution

Campus Bio-Medico University of Rome

Project objectives

Scopo dello studio RIVENDEL è valutare l’effetto del trattamento con ivabradina sulla funzione endoteliale in pazienti affetti da cardiopatia ischemica sottoposti a angioplastica coronarica.

Start and end date

2013 - 2014

Project Manager

  • Dott. Fabio Mangiacapra, Coordinatore
  • Prof. Germano di Sciascio

Coordinating institution of the project

Campus Bio-Medico University of Rome

2023© Università Campus Bio-Medico di Roma, Via Álvaro del Portillo, 21 - 00128 Rome, Tel. +39 06.22541.1, Fax +39 06.22541.456, VAT number: 048 020 51 005, Fiscal Code: 97087620585
magnifiercrossmenuchevron-downchevron-leftchevron-right